Key result
Heart transplantation and VADs remain necessary for doxorubicin-induced HF refractory to standard medical therapy.
Why the study?
Doxorubicin-induced heart failure is rare, difficult to treat, and does not respond to usual medical therapies, necessitating evaluation of surgical options.
What are the surgical options and their efficacy for patients with doxorubicin-induced heart failure?
What are the surgical options and their efficacy for patients with doxorubicin-induced heart failure?
Answers are grounded in this paper and cite their sources.
For doxorubicin-induced heart failure refractory to medical therapy, surgical options like cardiac transplantation and ventricular assist devices are necessary interventions.
Doxorubicin-induced heart failure is a rare, but serious illness and is well-known to be difficult to treat. Prevention strategies have not demonstrated the expected success and unfortunately, this specific type of heart failure does not respond to the usual medical therapies as do other kinds of heart failure. Therefore, surgical procedures may be necessary in some patients. Cardiac transplantation is performed in most cases but this requires cure of the neoplastic disease. This usually requires a recurrence-free interval of several years which is associated with a high attrition rate in these patients due to their cardiac disease. Therefore, ventricular assist devices may be implanted in selected patients as a bridge to transplantation or destination therapy. This review focuses on the surgical options for doxorubicin-induced heart failure and discusses their efficacy as well as their clinical applicability.
No takes yet. Share an insight, caveat, or question.
Sara Nysom Christiansen (2010) conducted a review in Doxorubicin-induced heart failure. Surgical options (cardiac transplantation, ventricular assist devices) was evaluated. Surgical options like cardiac transplantation and ventricular assist devices are necessary for doxorubicin-induced heart failure, which typically does not respond to standard medical therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: